Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors - a smart fighter that destroys cancer cells for days without tiring.

Explore a high-throughput picodroplet-based method for CAR-T cell functional validation that enables rapid, single-cell ...

A bold funding initiative aims to help scientists predict a T cell’s target antigens, with implications far beyond cancer ...

Chimeric antigen receptor t-cell, or CAR-T therapy, uses a person’s own immune cells to attack cancer. Dean Berhaupt is the ...

The mammalian immune system is an evolutionary wonder. It's capable of recognizing and destroying cancer cells, and it can ...

This revolutionary approach has given hope to patients who previously had limited or no options, particularly those battling ...

Ischemic heart disease is a common consequence of coronary artery disease (CAD), which is primarily driven by atherosclerosis, a chronic inflammatory ...

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...

A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first ...

Treatment of B-cell Acute Lymphoblastic Leukaemia has improved thanks to CAR-T therapies, but relapse is still very common.